Last reviewed · How we verify
NCT04043780
Clinical Validation of a Decompression Prototype Splint for Patients With Carpal Tunel Syndrome
NA trial testing Decompression prototype splint for carpal tunnel syndrome in Carpal Tunnel Syndrome in 60 participants. Completed in 1 September 2020.
1 March 2020
Quick facts
| Lead sponsor | Universidad de Zaragoza |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 24 September 2019 |
| Primary completion | 1 March 2020 |
| Estimated completion | 1 September 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Decompression prototype splint for carpal tunnel syndrome
- Standard splint for carpal tunnel syndrome
Conditions studied
- Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →
Sponsor
Universidad de Zaragoza — full company profile →
Who can join
18 and older, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A multicentric randomized controlled trial has been designed to study the effects of a decompression prototype splint on symptoms, functional capacity and nerve conduction studies in patients with carpal tunnel syndrome.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Splinting for carpal tunnel syndrome.
Karjalainen TV, Lusa V, Page MJ, O'Connor D, et al · · 2023 · cited 15× · PMID 36848651 · DOI 10.1002/14651858.cd010003.pub2
Verify or expand the search:
- PubMed search for NCT04043780
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Carpal Tunnel Syndrome
Currently open trials in the same condition.
- NCT07312123 — A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome · NA · recruiting
- NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method · NA · recruiting
- NCT07414069 — High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes · NA · recruiting
- NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome · recruiting
- NCT06905769 — Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient · NA · active not recruiting
Other Universidad de Zaragoza trials
Trials by the same sponsor.
- NCT07497217 — Change in ATOR Screening Test Scores Over 12 Weeks · NA · recruiting
- NCT07395830 — Effects of a Multisensory VR Experience on Stress and User Experience · NA · not yet recruiting
- NCT07398040 — Clinical Impact of an Anti-Inflammatory Diet in Anxiety and Depression With AI · NA · enrolling by invitation
- NCT07066696 — Mindfulness and Compassion Program for the Improvement of Emotional and Behavioral Problems, Academic Performance and Sc · NA · not yet recruiting
- NCT07086209 — Optimizing Hamstring Rehabilitation With Amino Acids · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04043780 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de Zaragoza
- Last refreshed: 4 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04043780.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing